Hims & Hers said the U.S. FDA's decision that the shortage of Novo Nordisk's weight-loss and diabetes drugs had been resolved ...

Queer Eye star Jonathan Van Ness revealed a dramatic weight loss transformation with side-by-side mirror selfies shared to ...

Shares of Hims & Hers Health (HIMS) shares plunged in late trading Monday after the company reported falling margins as costs ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

Jonathan Van Ness has been on a weight loss journey and he's sharing an update on how things are going so far. The Queer Eye ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

There’s evidence that the demographic of people on the drugs overlaps with those who like to spend, a group some analysts ...

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...

Life on a fastball means movement. When Williams' fastball is right, it rides up on a hitter. Vogt has seen that ride ...

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...